<img alt="" src="https://secure.lazy8krti.com/218831.png" style="display:none;">

Living with Crohn's Disease

EU & Japan reports

“Living with Crohn's Disease” is a syndicated report which offers valuable insights into patient attitudes and behaviour.

We recognise pharma brands need access to unique patient insights if they are to develop effective products, treatments and relevant communications messages. Living with Crohn's disease (CD) is designed to provide in-depth understanding of the disease patient journey, from diagnosis through treatment and ongoing management. It unveils patients attitudes, needs and support required at key stages of the journey.

Gain an in-depth understanding of:

  • Diagnosis pathway of CD patients
  • Extent to which the condition impacts day-to-day activities
  • Degree of stress / anxiety associated with CD
  • Symptoms that have the greatest impact on sufferers
  • Reasons for delay in treatment initiation
  • Level of satisfaction with current treatment and patient unmet needs
  • Awareness of new products 

Methodologies 

Living with Crohn's Disease EU

Methodology Quant: 30-minute online surveys with patients suffering from CD
Qual: 30-minute qualitative telephone interviews with patients suffering from CD
Countries France Germany Italy Spain  UK Total 
Total 

France53

Germany53

Italy54 Spain53 UK53 EU266
Sample considerations
  • All patients were required to be diagnosed with Crohn’s disease by a doctor and receiving at least one prescription medication
  • Quotas were in place to regulate key characteristics / demographics (age, gender and current treatment type) to ensure sufficient sample for sub analysis


Living with Crohn's Disease Japan

Methodology

Quant: 30-minute quantitative online surveys with patients suffering from CD
Qual: 30-minute qualitative telephone interviews with patients suffering from CD

Countries Japan
Total 

Japan55

Sample considerations
  • All patients were required to be diagnosed with Crohn’s disease by a doctor and receiving at least one prescription medication
  • Quotas were in place to regulate key characteristics / demographics (age, gender and current treatment type)

Request more information on Living With

mariel-web-image

Mariel Metcalfe

Director, Head of Living With

Mariel is the Head of Living With and has 18 years of pharmaceutical market research experience in a wide variety of qualitative and quantitative methodologies, including global tracker research and segmentation. She has worked in a variety of therapy areas including infectious, autoimmune, respiratory and metabolic diseases. Mariel has extensive experience in patient insights and is committed to bringing the patient voice to life. She has written multiple articles and hosts the podcast ‘Living with Chronic Illness’ which is designed to give a voice to patients suffering from chronic conditions.